
ãCOVIDã«ããæ»äº¡ã®ã»ãŒåæ°ã¯ãŠã€ã«ã¹ãçŽæ¥ã®åå ã§ã¯ãªãããšç ç©¶è ãçºè¡š
å èšäºã¯ãã¡ããã/Click here to read the original article.
2022幎1æãã8æã®éã«ã¢ããã®7ã€ã®ç é¢ã§çºçããæ»äº¡äŸã調æ»ããã®ãªã·ã£ã®å»åž«ãšç ç©¶è ã®ããŒã ã¯ããŠã€ã«ã¹ãçŽæ¥ã®åå ãšãªã£ãã®ã¯å šäœã®ããã4åã®1ã«éããªãã£ããšçµè«ã¥ããŸããã
ã¢ããïŒã®ãªã·ã£ïŒã®ç é¢ã§ã¯ãæ°çŸä»¶ã®æ»äº¡äŸã誀ã£ãŠCOVID-19ã«ãããã®ãšãããããšããæææ¥ã«ç§åŠèªãScientific Reportsãã«æ²èŒãããæ»èªä»ãç ç©¶ã«ãã£ãŠæããã«ãªããŸããã
19人ã®ã®ãªã·ã£äººå»åž«ããã³ç ç©¶è ã®ããŒã ãã2022幎1æãã8æã«ãããŠã¢ããã®7ã€ã®ç é¢ã§çºçãã530ä»¶ã®æ»äº¡äŸã調æ»ãããšãããCOVID-19ã«èµ·å ãããšãããæ»äº¡ã®ã»ãŒåæ°ããå®éã«ã¯ãŠã€ã«ã¹ãšã¯ç¡é¢ä¿ã ã£ãããšãåãããŸããã
ç ç©¶ããŒã ã¯ããŠã€ã«ã¹ãçŽæ¥ã®åå ãšãªã£ãã®ã¯ããã133ä»¶ïŒ25.1%ïŒã«ãšã©ãŸããšå€æããŸããã
ããã«157ä»¶ïŒ29.6%ïŒã§ã¯ãCOVID-19ããæ»äº¡ã«è³ãäžé£ã®éçšã«é¢äžãããŠãããšãããåèš290ä»¶ããCOVID-19ã«ããæ»äº¡ããšåé¡ãããŸããã
äžæ¹ã§ãæ®ãã®240ä»¶ïŒ45.3%ïŒã¯ãæ£è ããCOVID-19ã«ææããŠããããã®ã®ãæ»å ãšããŠçŽæ¥çµã³ã€ããããšã¯ã§ããŸããã§ããã
Childrenâs Health Defenseã®äžçŽç ç©¶ç§åŠè ã§ããã«ãŒã«ã»ãžã£ããããŠã¹ãå士ã¯ãæ¬æã§ã¯è§ŠããããŠããªãããä»éãã衚ã«ç€ºãããããäžã€ã®éèŠãªçµæã«æ³šç®ããŠããŸãã
ãžã£ããããŠã¹ãæ°ã«ãããšãã¯ã¯ãã³æ¥çš®ç¶æ³ã倿ããŠããããã€ãCOVID-19ã«ãã£ãŠæ»äº¡ããããšããã288人ã®ãã¡ã忰以äžïŒ53.8%ã155人ïŒã¯ãå®å šæ¥çš®ãŸãã¯ããŒã¹ã¿ãŒæ¥çš®ãåããŠãããšãããŸãã
ããã®155人ã®ãã¡ã65.8%ïŒ102人ïŒã¯ããŒã¹ã¿ãŒæ¥çš®æžã¿ã§ããããšåœŒã¯è¿°ã¹ãŠããŸãã
ç ç©¶ã§ã¯ããã«ä»¥äžã®ç¹ãæããã«ãªããŸããïŒ
æ»äº¡èšºææžã®äžæ£ç¢ºãããCOVID-19ã«ããæ»äº¡æ°ã®éå€§å ±åã«ã€ãªãã£ãŠããã
é¢å ææã®èª€åé¡ãç¹ã«è¥å¹Žå±€æ£è ã«ãããŠé¡èã§ãã£ãã
ãCOVID-19ã§æ»äº¡ãããæ£è ãšãCOVID-19ãšãšãã«æ»äº¡ãããæ£è ã®éã§ãæ²»çå 容ã«å€§ããªéããèŠãããã
å ¬è¡è¡çå»åž«ã§ãã€ãªãã¯ãããžãŒã³ã³ãµã«ã¿ã³ãã®ãã€ãããã»ãã«å»åž«ã¯ãããã®ç ç©¶ã¯ã2020幎åé ããä»ã®ç ç©¶ã§ã瀺ãããŠããããšãè£ä»ããŠããããšè¿°ã¹ãŠããŸãã
ãéèŠãªã®ã¯ããã€ãã£ãŒç³»åã®åŠè¡èªã«æ²èŒããããšããäºå®ã§ããããã¯ã忥çèŠè«ãããçå®ãéèŠããæ¹åãžãšãåºç瀟ãç«ã¡æ»ãã€ã€ããå åãšãããã§ãããããšãã«å»åž«ã¯èªããŸããã
ãScientific Reportsããçºè¡ããã¹ããªã³ã¬ãŒã»ãã€ãã£ãŒã¯ãäžçæå€§ã®åŠè¡åºç瀟ã§ãã
å ç§å»ã®ã¯ã¬ã€ãã³ã»Jã»ãã€ã«ãŒå士ã¯ãããã³ãããã¯ãããã ãé²ãã æ®µéã§ãå ¬åŒã®æ»äº¡å ±åãããã»ã©èªåŒµãããŠãããšããäºå®ã¯ãéå°å ±åãæå³çã§ãã£ãå¯èœæ§ã匷ã瀺åããŠããããšè¿°ã¹ãŠããŸãã
ãã®ä»ã®äž»ãªç ç©¶çµæïŒ
ãCOVID-19ãšãšãã«æ»äº¡ãããæ£è ã¯å¹³åããŠè¥ããå ç«æå¶ç¶æ ã§ãã£ãããæ«æèçŸæ£ãåºåœ¢ãããªã©ã®é節ãªçŸæ£ãæ±ããŠããå²åãé«ãã£ãã
ãCOVID-19ã§æ»äº¡ãããæ£è ã¯ãé«éœ¢ã§ããããšãå€ããææçç æ£ãžã®å ¥é¢ãäœé žçŽ çãåŒåžå°é£ãªã©ã®ãCOVID-19ã«äžèŽããçç¶ããé žçŽ çæ³ãã¬ã ãã·ãã«ã®æäžãªã©ãCOVID-19ç¹æã®æ²»çããåããŠããåŸåããã£ãã
COVID-19ãçŽæ¥ã®æ»å ãšããŠèšèŒããã204ä»¶ã®æ»äº¡èšºææžã®ãã¡ãèšåºçãªåè©äŸ¡ã®çµæãå®éã«ç¢ºèªãããã®ã¯132ä»¶ïŒ64.7%ïŒã®ã¿ã ã£ãã
COVID-19ãæ»å ã®äžå ãšããŠèšèŒããã324ä»¶ã®æ»äº¡èšºææžã®ãã¡ãåè©äŸ¡ã§ç¢ºèªãããã®ã¯86ä»¶ïŒ26.5%ïŒã ã£ãã
å ¥é¢äžã«COVID-19ã«ææããæ£è ã¯ããCOVID-19ã§æ»äº¡ããããšèª€åé¡ããã確çã130%ïŒãªããºæ¯2.3ïŒé«ãã£ãã
ãCOVID-19ã«ããæ»äº¡æ°ã¯äººå·¥çã«æ°Žå¢ãããããšçµè«ã¥ããã®ã劥åœã
ç ç©¶è ãã¡ã¯ãã«ã«ãã®ãã¡ã€ã«ãèšåºã»æ€æ»ããŒã¿ã粟æ»ãã察象ãšãªã£ãæ£è ãæ²»çããŠããæ åœå»ã«å¯Ÿããèãåã調æ»ã宿œããŸããã
ç«åŠè ã®ãã³ã©ã¹ã»ãã«ã·ã£ãŒæ°ã¯ããã®ç ç©¶ã¯æ¹æ³è«çã«ä¿¡é Œã§ãããšè©äŸ¡ããŠããŸãã
ãå€ãã®ç ç©¶ãè¡æ¿ããŒã¿ã®ã³ãŒãã«äŸåããŠããã®ãšã¯ç°ãªããæ¬ç ç©¶ã§ã¯ã«ã«ãã®å šé¢çãªç²Ÿæ»ã䞻治å»ãžã®çŽæ¥ã€ã³ã¿ãã¥ãŒãå°éå®¶ã«ããç¬ç«ãã倿ãçµã¿åããããå æ¬çãªèšåºç£æ»ã宿œãããŠããŸãããšãã«ã·ã£ãŒæ°ã¯è¿°ã¹ãŠããŸãã
ç ç©¶è ãã¡ã¯ãããªãã¯ãã³æ ªã®æ³¢ãã®ææã«æ»äº¡ããäºäŸãéžãã çç±ã«ã€ããŠã説æããŠããŸããããã¯ãæ°ããå€ç°æ ªããææåã¯é«ããéçåçã¯äœããããšããããCOVID-19ã«ããå ¥é¢ãæ»äº¡ã®ãªã¹ã¯ãäœäžããããããå®éã«ã¯COVID-19ãçŽæ¥ã®æ»å ã§ãªãã±ãŒã¹ãå€ãå«ãŸããŠããå¯èœæ§ãé«ããšèããããããã§ãã
ãŸããèè ãã¯ã®ãªã·ã£ã«ãããŠãæ»äº¡æã«COVID-19æ€æ»ãéœæ§ã§ãã£ãæ£è ã®æ»äº¡ã¯ãã¹ãŠãå ¬åŒã«ã¯COVID-19é¢é£æ»ãšããŠåé¡ãããããšããç¹ã«ãèšåããŠããŸãã
ãã«ã·ã£ãŒæ°ã¯ãããã¯å€ãã®åœã§å ±éããŠè¡ãããŠããæ £è¡ã ãšè¿°ã¹ãŠããŸãã
ãåæ§ã®æ»äº¡åé¡ã®ææ³ã欧米諞åœã§ãåºãæ¡çšãããŠããããšãèãããšãCOVID-19ã«ããæ»äº¡æ°ãä»ã®åœã§ãåçšåºŠã«äººå·¥çã«æ°Žå¢ããããŠãããšçµè«ã¥ããã®ã¯åŠ¥åœã§ãããšããã«ã·ã£ãŒæ°ã¯èªããŸããã
ãã«å»åž«ã¯ããã®ãããªæ £è¡ã®èæ¯ã«ã¯ãæ¿åºãç é¢ã«æäŸãã財æ¿çããã³ãã®ä»ã®ã€ã³ã»ã³ãã£ãããã£ããšææããŠããŸãã
ãæ¥éã«éçºãããmRNAã¯ã¯ãã³ã«ãã£ãŠè«å€§ãªå©çãåŸããšããééçãªææããããå°æ¥ã«åããŠãã®åäŸãäœãæå³ããããŸããããšãã«å»åž«ã¯è¿°ã¹ãŸããããSARS-CoV-2ãŠã€ã«ã¹ã«ããææçã®å€ããæ¯èŒç軜çã§ãã£ãããšããã人ã ã«COVID-19ãå®éãããé¥ãã«æ·±å»ã§ãé¥ãã«èå»¶ããŠãããšæãããå¿ èŠããã£ãã®ã§ããã
ãžã£ããããŠã¹ãæ°ã¯ããã®ç ç©¶çµæã¯ãCOVID-19ãã³ãããã¯äžã®å ¬è¡è¡çäžã®æææ±ºå®ããç§åŠçãŸãã¯å»åŠçåºæºã§ã¯ãªããææãã«ãã£ãŠå°ãããŠããããšã瀺ããŠãããšèªã£ãŠããŸãã
ãåœæã®äž»æµã¡ãã£ã¢ã®äžã«ã¯ããŸãã§é§ãããã£ããã®ããã§ãã⊠ãããŠãã®é§ã¯åžžã«âææâã®åŽã«åã£ãŠãããçæ§çãªå€æãããææã«åºã¥ã決å®ãåªå ãããŠããã®ã§ããã
ãžã£ããããŠã¹ãæ°ã«ããã°ããã®ææã瀟äŒå šäœã«äžé£ã®æªåœ±é¿ãããããããšãããŸãã
ãCOVID-19ã«ããæ»äº¡ã®èªåŒµã«ã©ã®ãããªæå³ããã£ãã«ããããã®çµæãšããŠç§ãã¡ã¯èª€ã£ãéãé²ãã§ããŸããŸãã⊠ç§ãã¡ã¯å®¶ã«éããããããã¢ãéããããã¹ã¯ã§é¡ãèŠããŸãããå®éšçãªè¬ãã¯ã¯ãã³ãæäžããŸãããç é¢ã¯ãæ²»çã®å Žã§ã¯ãªã害ã®å Žãšãªã£ãŠããŸã£ãã®ã§ãããšåœŒã¯èªããŸããã